Papatheodoridis, G.V. Idilman, R. Dalekos, G.N. Buti, M. Chi, H. van Boemmel, F. Calleja, J.L. Sypsa, V. Goulis, J. Manolakopoulos, S. Loglio, A. Siakavellas, S. Keskın, O. Gatselis, N. Hansen, B.E. Lehretz, M. de la Revilla, J. Savvidou, S. Kourikou, A. Vlachogiannakos, I. Galanis, K. Yurdaydin, C. Berg, T. Colombo, M. Esteban, R. Janssen, H.L.A. Lampertico, P., The risk of hepatocellular carcinoma decreases after the first 5 years of entecavir or tenofovir in Caucasians with chronic hepatitis B, Annals of Hepatology, (66), 1444-1453, 2017, John Wiley and Sons Inc,